Gabapentin
NDC 53746-102, Gabapentin, capsule, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 53746-102
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078428
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53746-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53746-102-01 | 53746010201 | 100 CAPSULE in 1 BOTTLE (53746-102-01) |
| 53746-102-05 | 53746010205 | 500 CAPSULE in 1 BOTTLE (53746-102-05) |
| 53746-102-10 | 53746010210 | 1000 CAPSULE in 1 BOTTLE (53746-102-10) |
| 53746-102-30 | 53746010230 | 30 CAPSULE in 1 BOTTLE (53746-102-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b11dbff5-ceee-4a63-a093-f6efebdc2f6f
Use it
Look up 53746-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53746-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53746-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.